The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
The Effects of Amiodarone on the Thyroid*
Abstract
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T(4) and rT(3), and a decrease in serum T(3), concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T(3) from T(4) and a decrease in the clearance of rT(3). In 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AIH is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T(4) replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Perchlorate and the Thyroid Gland
Wolff, J. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01350-4 · Cited by 588
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370
Self-citationPhosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis
Tarui, S., Giichi, O., Ikura, Y., Tanaka, T., Suda, M., & Nishikawa, M. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90156-7 · Cited by 369
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
Cited by
Items 501–600 of 615
Fradera, I. Z. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Erkrankungen endokriner Drüsen
Mann, K., Schopohl, J., Petersenn, S., Saller, B., Janssen, O. E., Arlt, W., Zitzmann, M., Nieschlag, E., Wuttke, W., Hinney, B., et al. (2003) · Springer eBooks · doi:10.1007/978-3-662-12451-2_8
Thyroid Dysfunctions and its Monitoring
Pathak, N. M., & Kothiyal, P. (2013) · Pharmatutor
Calil‐Silveira, J. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2010.tde-20052010-144255
P245 - Les deux aspects anatomo-pathologiques de l’hyperthyroïdie induite par l’amiodarone
Nys, P., Cordray, J. P., & Merceron, R. E. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)82086-4
Vrndic, O. B., Živančević-Simonović, S., Dimitrijević, L., Djukić, A., & Arsenijević, N. (2010) · Medicinski pregled · doi:10.2298/mpns1002104v
Tarbox, M. B., & Bergfeld, W. F. (2008) · Springer eBooks · doi:10.1007/978-1-84800-187-9_11
Amiodarone Induced Thyrotoxicosis (Type II)
Ju, C. Y., Kim, H. K., Chung, H.-J., Park, Y., Kim, J. Y., Jung, S. M., Choi, S. J., Kang, G. H., & Shim, M. S. (2007) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2007.22.3.229
Dificultad en el tratamiento del hipertiroidismo por amiodarona: Presentación de un caso
Pedro, T., Martínez‐Hervás, S., Lorente, R., Catalá, M., Ortega, J., Real, J. T., & Carmena, R. (2007) · Anales de Medicina Interna · doi:10.4321/s0212-71992007001100007
Efectos de la amiodarona en el tiroides
López, M. E. D. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71462-6
To add amiodarone or not: That is the question
Zimmerman, M. J., & Gerson, M. C. (2008) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.10.003
The Incidence and Risk of Inducing Hyperthyroidism Following Amiodarone Treatment
Cozlea, D. L., Farcaș, D. M., Keresztesi, A.-A., Silivastru, I., Cozlea, L., & Caraşca, E. (2013) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2013-0031
A Case of Sunitinib-Induced Destructive Thyroiditis
Kim, B. K., Choi, Y. S., & Park, Y. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.1.68
Hipertiroidismo inducido por amiodarona
Arribas, C. R., Vich-Pérez, P., & Donoso, J. R. (2004) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(04)74279-3
Rapidly Progressive Severe Amiodarone‐Induced Hypothyroidism in an Elderly Female
Ghiculescu, R. A., & Martin, J. H. (2009) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2009.tb00438.x
Patterns of drugs prescribed concomitantly with levothyroxine in children with hypothyroidism
Pérez, A. G. (2012) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp11.618
Toxicidade da Amiodarona: Caso Clínico
Melo, N. C. V., Jaraquemada, T., & Gonçalves, A. (2005) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Zaidel, E. J., Ferrari, R. J., & de Trabajo, L. (2008) · DOAJ (DOAJ: Directory of Open Access Journals)
THE IMPACT OF THYROID DYSFUNCTION ON CARDIOVASCULAR RISK
Manuchehri, A. M. (2008) · Repository@Hull (Worktribe) (University of Hull)
Controllo periferico dell’azione degli ormoni tiroidei: dal laboratorio alla clinica
Luongo, C., & Salvatore, D. (2010) · L Endocrinologo · doi:10.1007/bf03344682
Mariotti, S. (2011) · doi:10.1093/med/9780199235292.003.0138
Eskelinen, S. I. (2008) · UTUPub (University of Turku)
Techniques et résultats des explorations radio-isotopiques de la thyroïde
Leger, A. N. (2006) · EMC - Radiologie et imagerie médicale - Cardiovasculaire - Thoracique - Cervicale · doi:10.1016/s1879-8535(06)74693-1
AN OVERVIEW OF CLINICAL ELECTROCARDIOGRAPHY
Baker, T., Nikolić, G., & O’Connor, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7295-3841-1.10003-6
Berdunov, V. (2016) · Nottingham ePrints (University of Nottingham)
Shah, A. M. (2016) · The Medicine Forum · doi:10.29046/tmf.017.1.014
Clinical Course and Predictors of Outcome
Conen, D., Melly, L., Kaufmann, C. C., Bilz, S., Ammann, P., Schaer, B. A., Sticherling, C., Mueller, C. E., & Osswald, S. (2007)
Plinkert, P. K., & Wollenberg, H. B. (2014)
Braithwaite, S. S. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50063-7
Breda, D. R. L. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Classification and Etiopathogenesis of Hypothyroidism
Chiovato, L., Mariotti, S., & Magri, F. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_10-1
Two Unusual Situations of Excess Iodine Ingestion
Braverman, L. E. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374135-6.00097-2
Self-citationAmiodaron-induzierte Schilddrüsenprobleme: optimales Management
Binz-Siegmann, K. (2018) · Praxis · doi:10.1024/1661-8157/a002860
Iodine-induced thyroid disorders in the practice of a cardiologist
Makar, O., Izhytska, N. V., Fedechko, M. Y., Leshchuk, Y., Kulpok-Bagiński, T., Ślęzak, D., Nadolny, K., & Ładny, J. R. (2017) · Disaster and Emergency Medicine Journal · doi:10.5603/demj.2017.0026
Disfunción tiroidea inducida por amiodarona en pacientes portadores de arritmias
Hung, C. Y., Chacín, A. M., Bracchitta, G., Oliveros, H. E. G., Hung, M.-L., & Pérez, A. J. (2018) · Medicina Interna
La gestione del paziente nella tireotossicosi e nell’ipotiroidismo indotti da amiodarone
Bogazzi, F., Brogioni, S., Cosci, C., Dell'Unto, E., & Martino, E. (2004) · L Endocrinologo · doi:10.1007/bf03344487
Self-citationBuldygina, Y. V., Terekhova, H. М., & Pankiv, V. І. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.3.2018.136423
Gyógyszer-indukált hyperthyreosisok
Erdei, A., Paragh, G., Gazdag, A., Bodor, M., Boda, J., & Nagy, E. V. (2013) · University of Debrecen Electronic Archive (University of Debrecen)
Wémeau, J.-L. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-07464-6.50017-3
Fontan Patient With Brady and Tachyarrhythmia Issues
Balaji, S., Mandapati, R., & Webb, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-48568-5.00010-x
Probing the distribution of pharmaceutical compounds in cells using ToF-SIMS
Newman, C. A. F. F. (2019) · Nottingham ePrints (University of Nottingham)
Prevention and Treatment of Iodine-Induced Thyrotoxicosis
Kolcsár, M., & Gáll, Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89615
Amiodaron i funkcija štitnjače [Amiodarone and the thyroid function]
Jukić, T., Punda, M., Franceschi, M., Staničić, J., Granić, R., & Kusić, Z. (2015) · Dr Med - University of Zagreb School of Medicine Digital Repository
Cohen, R. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00023-7
C’è un problema con la tiroide? Attenzione ai farmaci!
Trimarchi, F., & Ruggeri, R. M. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00719-x
Die Schilddrüse im Alter: Physiologie und Pathologie
Tugendsam, C., & Kurtaran, A. (2020) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-020-00761-2
- Rare Forms of Thyrotoxicosis
Monaco, F. (2012) · CRC Press eBooks · doi:10.1201/b12117-26
New advancements in thyroid surgery
Slycke, S. V. (2020) · Ghent University Academic Bibliography (Ghent University)
Stress hyperglycaemia and endocrine emergencies
Gunst, J., Debaveye, Y. A., & den Berghe, G. V. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0068
AMIODARONE INDUCED THYROTOXICOSIS - REVIEW OF TREATMENT
Sutrisna, E. (2021) · Journal of Bio Innovation · doi:10.46344/jbino.2021.v10i2b.04
Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
Tsoy, U. A., Shekhovtsova, A. A., Иваниха, E. В., Салов, М. А., Данилов, И. Н., Andreychenko, T. V., Dalmatova, A. B., Belousova, L., & Grineva, E. N. (2021) · Grekov s Bulletin of Surgery · doi:10.24884/0042-4625-2021-180-2-42-49
Effects of amiodarone on cardiac performance in arrhythmic dogs
Boonpala, P. (2014) · NRCT Data Center · doi:10.14457/cu.the.2014.1475
Cardot-Bauters, C. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-07464-6.50018-5
Fetal Effects of Drugs Commonly Used Critical Care
Yankowitz, J. (2004) · Wiley eBooks · doi:10.1002/9780470760086.ch43
Causes and Laboratory Investigations of Thyrotoxicosis
Latrofa, F., & Vitti, P. (2022) · doi:10.1093/med/9780198870197.003.0058
(2003) · Thyroid · doi:10.1089/105072503321087097
(2019) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-9655-4.ch006
Luíz, H. V., Manita, I., & Portugal, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_7
Dominguez, L. J., & Barbagallo, M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch83
Tiroiditis no autoinmunes y por fármacos
Evaa, M., Delgado, R., Laguno, C. P., Martín, L. N., Landa, I. C., & Muñoz, J. R. (2022) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2021.05.003
Cardot-Bauters, C. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77583-3.00021-6
Ratajczak, T., Zechiel, K., Overman, I., & Gupta, A. (2015) · Journal of Medical Cases · doi:10.14740/jmc2317w
Pathophysiology and management of thyroid disorders in the critically ill
O’Dwyer, M., & Watson, D. (2016) · doi:10.1093/med/9780199600830.003.0263
Wägner, A. M., & Sánchez, R. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-37393-0_209-1
Saller, B., & Janssen, O. E. (2006) · Springer eBooks · doi:10.1007/3-540-27385-9_60
de Malleray, C. P. (2007) · EMC - Urgenze · doi:10.1016/s1286-9341(07)70039-x
Kaiser, P., Hoess, C., Krause, M., & Pavlicek, V. (2008) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2008.06622
de Malleray, C. P. (2006) · EMC - Médecine d urgence · doi:10.1016/s1959-5182(06)73453-5
Thyroid Dysfunctions and the Vascular System
Wägner, A. M., & Sánchez, R. M. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_209
(2002) · Hospital Medicine · doi:10.12968/hosp.2002.63.12.1899
Sánchez, L. F. P., & Bajo, Á. V. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70122-8
Nadkarni, P. J., & Burman, K. D. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-177-6_1
Amiodaron-Induced Thyrotoxicosis
Данилова, Л. И., Короленко, Г. Г., & Lushchik, M. L. (2022) · Рецепт · doi:10.34883/pi.2022.25.3.004
A CLINICAL CASE OF CORDARONE-INDUCED THYROTOXICOSIS IN A PATIENT WITH PAROXYSM OF CILIARY ARYTHMIA
Кривелевич, Н. Б., Shilova, V. A., Науменко, Е. П., & Fedorenko, O. V. (2012) · Health and Ecology Issues · doi:10.51523/2708-6011.2012-9-1-18
AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
Dzhanashiya, P. K., Avdeeva, E. V., Krylova, N. S., Nikolenko, S. A., & Nazarenko, V. A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.15829/1560-4071-2009-3-53-56
Closa, M. S., Requena, A. P., García, S. S., & Ballarín, J. M. S. (2023) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2022.06.004
A Case Report on Amiodarone-Induced Toxicity Involving the Liver and Thyroid
Athul, H., Varghese, G. I., Mathew, J. K., Thomas, V., & Varghese, M. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr231031154605
The Perioperative Pharmacology
Wade, S. D., Sawicki, C. M., Smiley, M. K., Cuddy, M. A., Vukas, S., & Schwartz, P. J. (2024) · Wiley eBooks · doi:10.1002/9781394164929.ch5
Zherebchikova, K., Сергеевич, Б. Д., Ermolaeva, A. S., Омаровна, С. М., Sych, Y. P., Владиславович, Е. М., & Fadeev, V. V. (2024) · Consilium Medicum · doi:10.26442/20751753.2024.1.202665
Ventricular Tachycardia and Fibrillation: Amiodarone as a Safety and Prophylactic
Sunny, M., & nahar, K. (2024) · East African Scholars Journal of Medical Sciences · doi:10.36349/easms.2024.v07i06.005
Magnitude and time course of urinary iodine excretion in patients after amiodarone therapy
Marchionni, G., Pinto, G., Locatelli, M., Spoladore, R., Foppoli, L., Monaca, G., Margonato, A., & Fragasso, G. (2024) · Minerva Endocrinology · doi:10.23736/s2724-6507.24.04213-1
Krekeler, M. C. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10818
Correlation of Serum Creatinine with TSH in Overt Hypothyroidism Patients
Anil, K., & Subramanya, C. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr241124140820
Resistance to Thyroid Hormone (RTH) and Resistance to TSH (RTSH)
Lemelman, M. B., & Dumitrescu, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_17
Bhende, P. V., Mannari, J. G., Wagh, R., Parikh, V., Talavia, R., Patel, N., Chaudhary, R., Patel, M., & Rathod, M. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20250270
Bogazzi, F., Cappellani, D., & Tomisti, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00227-2
Self-citationWu, Q. (2013) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/e0fe-j7tr
Bernasconi, C., Sampani, S., Beronius, A., Coecke, S., Langezaal, I., Pistollato, F., Paini, A., Muñoz, A., Asturiol, D., Kienzler, A., et al. (2025) · ALTEX · doi:10.14573/altex.2501152s3
A real-world pharmacovigilance assessment of drug-related carcinoembryonic antigen increase
Du, C., Liang, Y., Liu, W., Jiang, Y., & Wang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044365
Stokum, J. A., Wilhelmy, B. E., Bragança, C., Tosun, Ç., Serra, R., Tsymbalyuk, O., Keledjian, K. M., Gerzanich, V., & Simard, J. M. (2025) · Journal of Neurotrauma · doi:10.1177/08977151251400735
Sixdorf, A. (2015) · Digitalen Hochschulbibliothek Sachsen-Anhalt (Universitäts- und Landesbibliothek Sachsen-Anhalt) · doi:10.25673/4297
Charakterisierung kritisch kranker Patienten mit Non-Thyroidal-Illness-Syndrom
Krug, N. (2019) · Qucosa (Saxon State and University Library Dresden)
Experiência profissionalizante na vertente de Investigação e Farmácia Comunitária
Ribeiro, D. C. N. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Frequência de disfunção tireoidiana induzida pelo uso de Amiodarona: resultados preliminares
Barros, A. C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Amiodarone-induced Thyrotoxicosis
Yelmaz, E. C., Saltabas, M. A., & Metin, A. (2025) · Bulletin of Cardiovasculer Academy · doi:10.4274/kvbulten.galenos.2025.60352
Ferreira, P. G., Barbosa, A. L., Gonçalves, J., Lopes, J., Fernandes, V. M. F. P., Grijó, C. M. S. P. M., Fonseca, A. M., Fernandes, C., Silva, C., Martins, P., et al. (2026) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2026.501800
医療関連データベースの解析によるアミオダロンの心外副作用に関する研究
木下, 佐. (2020) · Institutional Repositories DataBase (IRDB)
Chronic Thyroiditis: Hashimoto’s Disease
Sakr, M. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-19513-5_9
Mise en oeuvre de dosages pour le diagnostic précoce de l'hypothyroïdie
Iss, C. (2015) · theses.fr (ABES) · doi:10.70675/f9f2aeebza5a8z4cf3zb9afzd52e7504b286
Metadata
- Authors
- Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 240-254
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117317136
- Cited by
- 551
- References
- 154
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.